nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—PGR—multiple sclerosis	0.0803	1	CbGaD
Betamethasone—Corticosteroid Hormone Receptor Agonists—Methylprednisolone—multiple sclerosis	0.0568	0.215	CiPCiCtD
Betamethasone—Corticosteroid Hormone Receptor Agonists—Dexamethasone—multiple sclerosis	0.0547	0.207	CiPCiCtD
Betamethasone—Corticosteroid Hormone Receptor Agonists—Triamcinolone—multiple sclerosis	0.0528	0.2	CiPCiCtD
Betamethasone—Corticosteroid Hormone Receptor Agonists—Prednisolone—multiple sclerosis	0.0511	0.194	CiPCiCtD
Betamethasone—Corticosteroid Hormone Receptor Agonists—Prednisone—multiple sclerosis	0.0483	0.183	CiPCiCtD
Betamethasone—brain cancer—Triamcinolone—multiple sclerosis	0.041	0.273	CpDpCtD
Betamethasone—Methylprednisolone—multiple sclerosis	0.0404	0.211	CrCtD
Betamethasone—Dexamethasone—multiple sclerosis	0.0398	0.207	CrCtD
Betamethasone—Triamcinolone—multiple sclerosis	0.0389	0.202	CrCtD
Betamethasone—Prednisone—multiple sclerosis	0.0369	0.192	CrCtD
Betamethasone—Prednisolone—multiple sclerosis	0.036	0.188	CrCtD
Betamethasone—brain cancer—Methylprednisolone—multiple sclerosis	0.0284	0.189	CpDpCtD
Betamethasone—PLA2G1B—Dexamethasone—multiple sclerosis	0.0233	0.204	CbGbCtD
Betamethasone—brain cancer—Dexamethasone—multiple sclerosis	0.0223	0.149	CpDpCtD
Betamethasone—colon cancer—Dexamethasone—multiple sclerosis	0.0223	0.149	CpDpCtD
Betamethasone—NR3C2—Prednisolone—multiple sclerosis	0.0176	0.154	CbGbCtD
Betamethasone—kidney cancer—Dexamethasone—multiple sclerosis	0.0161	0.107	CpDpCtD
Betamethasone—prostate cancer—Dexamethasone—multiple sclerosis	0.0116	0.0777	CpDpCtD
Betamethasone—NR3C2—Dexamethasone—multiple sclerosis	0.0104	0.0906	CbGbCtD
Betamethasone—NR3C1—Methylprednisolone—multiple sclerosis	0.00904	0.079	CbGbCtD
Betamethasone—breast cancer—Dexamethasone—multiple sclerosis	0.00818	0.0546	CpDpCtD
Betamethasone—NR3C1—Triamcinolone—multiple sclerosis	0.00685	0.0599	CbGbCtD
Betamethasone—PGR—Dexamethasone—multiple sclerosis	0.00669	0.0585	CbGbCtD
Betamethasone—NR3C1—Prednisolone—multiple sclerosis	0.0058	0.0507	CbGbCtD
Betamethasone—NR3C1—Prednisone—multiple sclerosis	0.00548	0.0479	CbGbCtD
Betamethasone—PTGS2—Triamcinolone—multiple sclerosis	0.00484	0.0423	CbGbCtD
Betamethasone—CYP19A1—Dexamethasone—multiple sclerosis	0.00376	0.0329	CbGbCtD
Betamethasone—NR3C1—Dexamethasone—multiple sclerosis	0.00342	0.0299	CbGbCtD
Betamethasone—PTGS2—Dexamethasone—multiple sclerosis	0.00241	0.0211	CbGbCtD
Betamethasone—ABCB1—Methylprednisolone—multiple sclerosis	0.0021	0.0184	CbGbCtD
Betamethasone—CYP3A4—Fingolimod—multiple sclerosis	0.00196	0.0171	CbGbCtD
Betamethasone—ABCB1—Mitoxantrone—multiple sclerosis	0.00154	0.0134	CbGbCtD
Betamethasone—ABCB1—Prednisolone—multiple sclerosis	0.00135	0.0118	CbGbCtD
Betamethasone—Fluticasone furoate—Dexamethasone—multiple sclerosis	0.00133	0.00936	CrCrCtD
Betamethasone—Fluticasone furoate—Triamcinolone—multiple sclerosis	0.0013	0.00914	CrCrCtD
Betamethasone—ABCB1—Prednisone—multiple sclerosis	0.00128	0.0112	CbGbCtD
Betamethasone—CYP3A4—Methylprednisolone—multiple sclerosis	0.00126	0.011	CbGbCtD
Betamethasone—Flurandrenolide—Methylprednisolone—multiple sclerosis	0.00125	0.00884	CrCrCtD
Betamethasone—Flurandrenolide—Dexamethasone—multiple sclerosis	0.00123	0.0087	CrCrCtD
Betamethasone—Flumethasone Pivalate—Methylprednisolone—multiple sclerosis	0.00121	0.00854	CrCrCtD
Betamethasone—Flumethasone Pivalate—Dexamethasone—multiple sclerosis	0.00119	0.00841	CrCrCtD
Betamethasone—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.00117	0.00827	CrCrCtD
Betamethasone—Difluprednate—Methylprednisolone—multiple sclerosis	0.00117	0.00827	CrCrCtD
Betamethasone—Halobetasol Propionate—Methylprednisolone—multiple sclerosis	0.00117	0.00827	CrCrCtD
Betamethasone—Flumethasone Pivalate—Triamcinolone—multiple sclerosis	0.00116	0.00822	CrCrCtD
Betamethasone—Halobetasol Propionate—Dexamethasone—multiple sclerosis	0.00115	0.00814	CrCrCtD
Betamethasone—Difluprednate—Dexamethasone—multiple sclerosis	0.00115	0.00814	CrCrCtD
Betamethasone—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.00115	0.00814	CrCrCtD
Betamethasone—Difluprednate—Triamcinolone—multiple sclerosis	0.00113	0.00795	CrCrCtD
Betamethasone—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.00113	0.00795	CrCrCtD
Betamethasone—Halobetasol Propionate—Triamcinolone—multiple sclerosis	0.00113	0.00795	CrCrCtD
Betamethasone—Flurandrenolide—Prednisolone—multiple sclerosis	0.00112	0.00787	CrCrCtD
Betamethasone—Testolactone—Methylprednisolone—multiple sclerosis	0.0011	0.00778	CrCrCtD
Betamethasone—Clocortolone—Methylprednisolone—multiple sclerosis	0.0011	0.00778	CrCrCtD
Betamethasone—Fluocinonide—Methylprednisolone—multiple sclerosis	0.0011	0.00778	CrCrCtD
Betamethasone—Prednicarbate—Methylprednisolone—multiple sclerosis	0.0011	0.00778	CrCrCtD
Betamethasone—Fluocinonide—Dexamethasone—multiple sclerosis	0.00108	0.00765	CrCrCtD
Betamethasone—Testolactone—Dexamethasone—multiple sclerosis	0.00108	0.00765	CrCrCtD
Betamethasone—Beclomethasone—Dexamethasone—multiple sclerosis	0.00108	0.00765	CrCrCtD
Betamethasone—Clocortolone—Dexamethasone—multiple sclerosis	0.00108	0.00765	CrCrCtD
Betamethasone—Prednicarbate—Dexamethasone—multiple sclerosis	0.00108	0.00765	CrCrCtD
Betamethasone—Fluocortolone—Methylprednisolone—multiple sclerosis	0.00107	0.00755	CrCrCtD
Betamethasone—Prednicarbate—Triamcinolone—multiple sclerosis	0.00106	0.00748	CrCrCtD
Betamethasone—Testolactone—Triamcinolone—multiple sclerosis	0.00106	0.00748	CrCrCtD
Betamethasone—Beclomethasone—Triamcinolone—multiple sclerosis	0.00106	0.00748	CrCrCtD
Betamethasone—Fluocinonide—Triamcinolone—multiple sclerosis	0.00106	0.00748	CrCrCtD
Betamethasone—Clocortolone—Triamcinolone—multiple sclerosis	0.00106	0.00748	CrCrCtD
Betamethasone—Fluocortolone—Dexamethasone—multiple sclerosis	0.00105	0.00743	CrCrCtD
Betamethasone—Alclometasone—Methylprednisolone—multiple sclerosis	0.00104	0.00734	CrCrCtD
Betamethasone—Fluocinolone Acetonide—Methylprednisolone—multiple sclerosis	0.00104	0.00734	CrCrCtD
Betamethasone—Fluocortolone—Triamcinolone—multiple sclerosis	0.00103	0.00726	CrCrCtD
Betamethasone—Fluocinolone Acetonide—Dexamethasone—multiple sclerosis	0.00102	0.00723	CrCrCtD
Betamethasone—Alclometasone—Dexamethasone—multiple sclerosis	0.00102	0.00723	CrCrCtD
Betamethasone—Budesonide—Methylprednisolone—multiple sclerosis	0.00101	0.00715	CrCrCtD
Betamethasone—Prednicarbate—Prednisone—multiple sclerosis	0.00101	0.0071	CrCrCtD
Betamethasone—Testolactone—Prednisone—multiple sclerosis	0.00101	0.0071	CrCrCtD
Betamethasone—Fluocinolone Acetonide—Triamcinolone—multiple sclerosis	0.001	0.00706	CrCrCtD
Betamethasone—Alclometasone—Triamcinolone—multiple sclerosis	0.001	0.00706	CrCrCtD
Betamethasone—Amcinonide—Dexamethasone—multiple sclerosis	0.000996	0.00703	CrCrCtD
Betamethasone—Budesonide—Dexamethasone—multiple sclerosis	0.000996	0.00703	CrCrCtD
Betamethasone—Fluoxymesterone—Dexamethasone—multiple sclerosis	0.000996	0.00703	CrCrCtD
Betamethasone—Diflorasone—Methylprednisolone—multiple sclerosis	0.000986	0.00696	CrCrCtD
Betamethasone—Flunisolide—Methylprednisolone—multiple sclerosis	0.000986	0.00696	CrCrCtD
Betamethasone—Fludrocortisone—Methylprednisolone—multiple sclerosis	0.000986	0.00696	CrCrCtD
Betamethasone—Clobetasol propionate—Methylprednisolone—multiple sclerosis	0.000986	0.00696	CrCrCtD
Betamethasone—Prednisone—Methylprednisolone—multiple sclerosis	0.000986	0.00696	CrCrCtD
Betamethasone—Desonide—Methylprednisolone—multiple sclerosis	0.000986	0.00696	CrCrCtD
Betamethasone—Beclomethasone—Prednisolone—multiple sclerosis	0.000981	0.00693	CrCrCtD
Betamethasone—Prednicarbate—Prednisolone—multiple sclerosis	0.000981	0.00693	CrCrCtD
Betamethasone—Clocortolone—Prednisolone—multiple sclerosis	0.000981	0.00693	CrCrCtD
Betamethasone—Testolactone—Prednisolone—multiple sclerosis	0.000981	0.00693	CrCrCtD
Betamethasone—Fluocortolone—Prednisone—multiple sclerosis	0.000976	0.00689	CrCrCtD
Betamethasone—Budesonide—Triamcinolone—multiple sclerosis	0.000974	0.00687	CrCrCtD
Betamethasone—Fluoxymesterone—Triamcinolone—multiple sclerosis	0.000974	0.00687	CrCrCtD
Betamethasone—Amcinonide—Triamcinolone—multiple sclerosis	0.000974	0.00687	CrCrCtD
Betamethasone—Prednisone—Dexamethasone—multiple sclerosis	0.000971	0.00685	CrCrCtD
Betamethasone—Clobetasol propionate—Dexamethasone—multiple sclerosis	0.000971	0.00685	CrCrCtD
Betamethasone—Fludrocortisone—Dexamethasone—multiple sclerosis	0.000971	0.00685	CrCrCtD
Betamethasone—Diflorasone—Dexamethasone—multiple sclerosis	0.000971	0.00685	CrCrCtD
Betamethasone—Flunisolide—Dexamethasone—multiple sclerosis	0.000971	0.00685	CrCrCtD
Betamethasone—Desonide—Dexamethasone—multiple sclerosis	0.000971	0.00685	CrCrCtD
Betamethasone—Paramethasone—Methylprednisolone—multiple sclerosis	0.000961	0.00679	CrCrCtD
Betamethasone—CYP3A4—Triamcinolone—multiple sclerosis	0.000956	0.00836	CbGbCtD
Betamethasone—Fluocortolone—Prednisolone—multiple sclerosis	0.000953	0.00673	CrCrCtD
Betamethasone—Alclometasone—Prednisone—multiple sclerosis	0.000949	0.0067	CrCrCtD
Betamethasone—Prednisone—Triamcinolone—multiple sclerosis	0.000948	0.0067	CrCrCtD
Betamethasone—Desonide—Triamcinolone—multiple sclerosis	0.000948	0.0067	CrCrCtD
Betamethasone—Diflorasone—Triamcinolone—multiple sclerosis	0.000948	0.0067	CrCrCtD
Betamethasone—Fludrocortisone—Triamcinolone—multiple sclerosis	0.000948	0.0067	CrCrCtD
Betamethasone—Flunisolide—Triamcinolone—multiple sclerosis	0.000948	0.0067	CrCrCtD
Betamethasone—Clobetasol propionate—Triamcinolone—multiple sclerosis	0.000948	0.0067	CrCrCtD
Betamethasone—Paramethasone—Dexamethasone—multiple sclerosis	0.000946	0.00668	CrCrCtD
Betamethasone—Desoximetasone—Methylprednisolone—multiple sclerosis	0.000938	0.00662	CrCrCtD
Betamethasone—Fluocinolone Acetonide—Prednisolone—multiple sclerosis	0.000927	0.00654	CrCrCtD
Betamethasone—Alclometasone—Prednisolone—multiple sclerosis	0.000927	0.00654	CrCrCtD
Betamethasone—Paramethasone—Triamcinolone—multiple sclerosis	0.000925	0.00653	CrCrCtD
Betamethasone—Amcinonide—Prednisone—multiple sclerosis	0.000924	0.00652	CrCrCtD
Betamethasone—Budesonide—Prednisone—multiple sclerosis	0.000924	0.00652	CrCrCtD
Betamethasone—Desoximetasone—Dexamethasone—multiple sclerosis	0.000923	0.00652	CrCrCtD
Betamethasone—CYP3A4—Mitoxantrone—multiple sclerosis	0.00092	0.00804	CbGbCtD
Betamethasone—Triamcinolone—Methylprednisolone—multiple sclerosis	0.000916	0.00647	CrCrCtD
Betamethasone—Fluprednidene Acetate—Methylprednisolone—multiple sclerosis	0.000916	0.00647	CrCrCtD
Betamethasone—Loteprednol—Methylprednisolone—multiple sclerosis	0.000916	0.00647	CrCrCtD
Betamethasone—Fluorometholone—Methylprednisolone—multiple sclerosis	0.000916	0.00647	CrCrCtD
Betamethasone—Mometasone—Methylprednisolone—multiple sclerosis	0.000916	0.00647	CrCrCtD
Betamethasone—Desoximetasone—Triamcinolone—multiple sclerosis	0.000902	0.00637	CrCrCtD
Betamethasone—Fluoxymesterone—Prednisolone—multiple sclerosis	0.000902	0.00637	CrCrCtD
Betamethasone—Amcinonide—Prednisolone—multiple sclerosis	0.000902	0.00637	CrCrCtD
Betamethasone—Budesonide—Prednisolone—multiple sclerosis	0.000902	0.00637	CrCrCtD
Betamethasone—Fluprednidene Acetate—Dexamethasone—multiple sclerosis	0.000901	0.00636	CrCrCtD
Betamethasone—Mometasone—Dexamethasone—multiple sclerosis	0.000901	0.00636	CrCrCtD
Betamethasone—Triamcinolone—Dexamethasone—multiple sclerosis	0.000901	0.00636	CrCrCtD
Betamethasone—Loteprednol—Dexamethasone—multiple sclerosis	0.000901	0.00636	CrCrCtD
Betamethasone—Fluorometholone—Dexamethasone—multiple sclerosis	0.000901	0.00636	CrCrCtD
Betamethasone—Flunisolide—Prednisone—multiple sclerosis	0.0009	0.00635	CrCrCtD
Betamethasone—Diflorasone—Prednisone—multiple sclerosis	0.0009	0.00635	CrCrCtD
Betamethasone—Clobetasol propionate—Prednisone—multiple sclerosis	0.0009	0.00635	CrCrCtD
Betamethasone—Desonide—Prednisone—multiple sclerosis	0.0009	0.00635	CrCrCtD
Betamethasone—Fludrocortisone—Prednisone—multiple sclerosis	0.0009	0.00635	CrCrCtD
Betamethasone—Rimexolone—Methylprednisolone—multiple sclerosis	0.000895	0.00632	CrCrCtD
Betamethasone—Dexamethasone—Methylprednisolone—multiple sclerosis	0.000895	0.00632	CrCrCtD
Betamethasone—Rimexolone—Dexamethasone—multiple sclerosis	0.000881	0.00622	CrCrCtD
Betamethasone—Mometasone—Triamcinolone—multiple sclerosis	0.000881	0.00622	CrCrCtD
Betamethasone—Fluorometholone—Triamcinolone—multiple sclerosis	0.000881	0.00622	CrCrCtD
Betamethasone—Loteprednol—Triamcinolone—multiple sclerosis	0.000881	0.00622	CrCrCtD
Betamethasone—Fluprednidene Acetate—Triamcinolone—multiple sclerosis	0.000881	0.00622	CrCrCtD
Betamethasone—Diflorasone—Prednisolone—multiple sclerosis	0.000878	0.0062	CrCrCtD
Betamethasone—Prednisone—Prednisolone—multiple sclerosis	0.000878	0.0062	CrCrCtD
Betamethasone—Desonide—Prednisolone—multiple sclerosis	0.000878	0.0062	CrCrCtD
Betamethasone—Clobetasol propionate—Prednisolone—multiple sclerosis	0.000878	0.0062	CrCrCtD
Betamethasone—Flunisolide—Prednisolone—multiple sclerosis	0.000878	0.0062	CrCrCtD
Betamethasone—Fludrocortisone—Prednisolone—multiple sclerosis	0.000878	0.0062	CrCrCtD
Betamethasone—Paramethasone—Prednisone—multiple sclerosis	0.000877	0.00619	CrCrCtD
Betamethasone—Dexamethasone—Triamcinolone—multiple sclerosis	0.000861	0.00608	CrCrCtD
Betamethasone—Rimexolone—Triamcinolone—multiple sclerosis	0.000861	0.00608	CrCrCtD
Betamethasone—Paramethasone—Prednisolone—multiple sclerosis	0.000856	0.00605	CrCrCtD
Betamethasone—Desoximetasone—Prednisone—multiple sclerosis	0.000856	0.00604	CrCrCtD
Betamethasone—Methylprednisolone—Dexamethasone—multiple sclerosis	0.000843	0.00595	CrCrCtD
Betamethasone—Prednisolone—Methylprednisolone—multiple sclerosis	0.000838	0.00592	CrCrCtD
Betamethasone—Triamcinolone—Prednisone—multiple sclerosis	0.000836	0.0059	CrCrCtD
Betamethasone—Mometasone—Prednisone—multiple sclerosis	0.000836	0.0059	CrCrCtD
Betamethasone—Fluprednidene Acetate—Prednisone—multiple sclerosis	0.000836	0.0059	CrCrCtD
Betamethasone—Loteprednol—Prednisone—multiple sclerosis	0.000836	0.0059	CrCrCtD
Betamethasone—Fluorometholone—Prednisone—multiple sclerosis	0.000836	0.0059	CrCrCtD
Betamethasone—Desoximetasone—Prednisolone—multiple sclerosis	0.000836	0.0059	CrCrCtD
Betamethasone—Prednisolone—Dexamethasone—multiple sclerosis	0.000825	0.00582	CrCrCtD
Betamethasone—Methylprednisolone—Triamcinolone—multiple sclerosis	0.000823	0.00581	CrCrCtD
Betamethasone—Rimexolone—Prednisone—multiple sclerosis	0.000817	0.00577	CrCrCtD
Betamethasone—Dexamethasone—Prednisone—multiple sclerosis	0.000817	0.00577	CrCrCtD
Betamethasone—Fluorometholone—Prednisolone—multiple sclerosis	0.000816	0.00576	CrCrCtD
Betamethasone—Triamcinolone—Prednisolone—multiple sclerosis	0.000816	0.00576	CrCrCtD
Betamethasone—Mometasone—Prednisolone—multiple sclerosis	0.000816	0.00576	CrCrCtD
Betamethasone—Fluprednidene Acetate—Prednisolone—multiple sclerosis	0.000816	0.00576	CrCrCtD
Betamethasone—Loteprednol—Prednisolone—multiple sclerosis	0.000816	0.00576	CrCrCtD
Betamethasone—CYP3A4—Prednisolone—multiple sclerosis	0.000809	0.00707	CbGbCtD
Betamethasone—Prednisolone—Triamcinolone—multiple sclerosis	0.000806	0.00569	CrCrCtD
Betamethasone—Hydrocortisone—Methylprednisolone—multiple sclerosis	0.000804	0.00568	CrCrCtD
Betamethasone—Rimexolone—Prednisolone—multiple sclerosis	0.000797	0.00563	CrCrCtD
Betamethasone—Dexamethasone—Prednisolone—multiple sclerosis	0.000797	0.00563	CrCrCtD
Betamethasone—ABCB1—Dexamethasone—multiple sclerosis	0.000796	0.00696	CbGbCtD
Betamethasone—Hydrocortisone—Dexamethasone—multiple sclerosis	0.000792	0.00559	CrCrCtD
Betamethasone—Methylprednisolone—Prednisone—multiple sclerosis	0.000781	0.00552	CrCrCtD
Betamethasone—Hydrocortisone—Triamcinolone—multiple sclerosis	0.000773	0.00546	CrCrCtD
Betamethasone—Prednisolone—Prednisone—multiple sclerosis	0.000765	0.0054	CrCrCtD
Betamethasone—CYP3A4—Prednisone—multiple sclerosis	0.000764	0.00668	CbGbCtD
Betamethasone—Methylprednisolone—Prednisolone—multiple sclerosis	0.000763	0.00538	CrCrCtD
Betamethasone—Hydrocortisone—Prednisone—multiple sclerosis	0.000734	0.00518	CrCrCtD
Betamethasone—Hydrocortisone—Prednisolone—multiple sclerosis	0.000716	0.00506	CrCrCtD
Betamethasone—ABCB1—Methotrexate—multiple sclerosis	0.00064	0.00559	CbGbCtD
Betamethasone—CYP3A4—Dexamethasone—multiple sclerosis	0.000477	0.00417	CbGbCtD
Betamethasone—PTGS2—leg—multiple sclerosis	0.000232	0.094	CbGeAlD
Betamethasone—NR3C1—nerve—multiple sclerosis	0.000146	0.059	CbGeAlD
Betamethasone—PLA2G1B—nervous system—multiple sclerosis	0.000123	0.05	CbGeAlD
Betamethasone—PLA2G1B—central nervous system—multiple sclerosis	0.000119	0.0481	CbGeAlD
Betamethasone—NR3C2—brainstem—multiple sclerosis	0.000117	0.0472	CbGeAlD
Betamethasone—NR3C2—retina—multiple sclerosis	0.000113	0.0456	CbGeAlD
Betamethasone—PLA2G1B—brain—multiple sclerosis	9.43e-05	0.0382	CbGeAlD
Betamethasone—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	9.41e-05	0.212	CbGdCrCtD
Betamethasone—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	9.26e-05	0.208	CbGdCrCtD
Betamethasone—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	9.05e-05	0.204	CbGdCrCtD
Betamethasone—NR3C2—medulla oblongata—multiple sclerosis	8.13e-05	0.0329	CbGeAlD
Betamethasone—NR3C2—midbrain—multiple sclerosis	7.43e-05	0.0301	CbGeAlD
Betamethasone—NR3C2—spinal cord—multiple sclerosis	7.25e-05	0.0294	CbGeAlD
Betamethasone—NR3C1—brainstem—multiple sclerosis	6.26e-05	0.0253	CbGeAlD
Betamethasone—NR3C2—nervous system—multiple sclerosis	6.11e-05	0.0247	CbGeAlD
Betamethasone—NR3C2—central nervous system—multiple sclerosis	5.88e-05	0.0238	CbGeAlD
Betamethasone—NR3C2—cerebellum—multiple sclerosis	5.75e-05	0.0233	CbGeAlD
Betamethasone—PGR—nervous system—multiple sclerosis	5.68e-05	0.023	CbGeAlD
Betamethasone—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	5.68e-05	0.128	CbGdCrCtD
Betamethasone—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	5.59e-05	0.126	CbGdCrCtD
Betamethasone—PGR—central nervous system—multiple sclerosis	5.47e-05	0.0221	CbGeAlD
Betamethasone—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	5.46e-05	0.123	CbGdCrCtD
Betamethasone—PGR—cerebellum—multiple sclerosis	5.35e-05	0.0216	CbGeAlD
Betamethasone—CYP19A1—nervous system—multiple sclerosis	5.11e-05	0.0207	CbGeAlD
Betamethasone—CYP19A1—central nervous system—multiple sclerosis	4.92e-05	0.0199	CbGeAlD
Betamethasone—NR3C2—brain—multiple sclerosis	4.67e-05	0.0189	CbGeAlD
Betamethasone—NR3C1—medulla oblongata—multiple sclerosis	4.36e-05	0.0177	CbGeAlD
Betamethasone—PGR—brain—multiple sclerosis	4.34e-05	0.0176	CbGeAlD
Betamethasone—NR3C1—midbrain—multiple sclerosis	3.99e-05	0.0161	CbGeAlD
Betamethasone—CYP19A1—brain—multiple sclerosis	3.91e-05	0.0158	CbGeAlD
Betamethasone—NR3C1—spinal cord—multiple sclerosis	3.89e-05	0.0157	CbGeAlD
Betamethasone—Fluticasone Propionate—PGR—multiple sclerosis	3.82e-05	0.387	CrCbGaD
Betamethasone—PTGS2—medulla oblongata—multiple sclerosis	3.78e-05	0.0153	CbGeAlD
Betamethasone—PTGS2—midbrain—multiple sclerosis	3.45e-05	0.014	CbGeAlD
Betamethasone—PTGS2—spinal cord—multiple sclerosis	3.37e-05	0.0136	CbGeAlD
Betamethasone—NR3C1—nervous system—multiple sclerosis	3.28e-05	0.0133	CbGeAlD
Betamethasone—ABCB1—retina—multiple sclerosis	3.23e-05	0.0131	CbGeAlD
Betamethasone—NR3C1—central nervous system—multiple sclerosis	3.16e-05	0.0128	CbGeAlD
Betamethasone—NR3C1—cerebellum—multiple sclerosis	3.08e-05	0.0125	CbGeAlD
Betamethasone—Triamcinolone—BCHE—multiple sclerosis	2.92e-05	0.296	CrCbGaD
Betamethasone—PTGS2—nervous system—multiple sclerosis	2.84e-05	0.0115	CbGeAlD
Betamethasone—PTGS2—central nervous system—multiple sclerosis	2.73e-05	0.0111	CbGeAlD
Betamethasone—PTGS2—cerebellum—multiple sclerosis	2.67e-05	0.0108	CbGeAlD
Betamethasone—NR3C1—brain—multiple sclerosis	2.51e-05	0.0101	CbGeAlD
Betamethasone—CYP3A4—nervous system—multiple sclerosis	2.48e-05	0.01	CbGeAlD
Betamethasone—CYP3A4—central nervous system—multiple sclerosis	2.39e-05	0.00966	CbGeAlD
Betamethasone—ABCB1—medulla oblongata—multiple sclerosis	2.34e-05	0.00946	CbGeAlD
Betamethasone—PTGS2—brain—multiple sclerosis	2.17e-05	0.00878	CbGeAlD
Betamethasone—ABCB1—midbrain—multiple sclerosis	2.13e-05	0.00864	CbGeAlD
Betamethasone—ABCB1—spinal cord—multiple sclerosis	2.08e-05	0.00843	CbGeAlD
Betamethasone—Dexamethasone—PGR—multiple sclerosis	2.04e-05	0.206	CrCbGaD
Betamethasone—ABCB1—nervous system—multiple sclerosis	1.75e-05	0.0071	CbGeAlD
Betamethasone—ABCB1—central nervous system—multiple sclerosis	1.69e-05	0.00684	CbGeAlD
Betamethasone—ABCB1—cerebellum—multiple sclerosis	1.65e-05	0.00669	CbGeAlD
Betamethasone—CYP19A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.65e-05	0.00232	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	1.61e-05	0.00226	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CCR2—multiple sclerosis	1.57e-05	0.00221	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—CD28—multiple sclerosis	1.56e-05	0.0022	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—CD80—multiple sclerosis	1.55e-05	0.00218	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—CCL2—multiple sclerosis	1.55e-05	0.00218	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—multiple sclerosis	1.53e-05	0.00215	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	1.49e-05	0.0021	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.49e-05	0.0021	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.49e-05	0.0021	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	1.48e-05	0.00209	CbGpPWpGaD
Betamethasone—PTGS2—Overview of nanoparticle effects—IL6—multiple sclerosis	1.48e-05	0.00208	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—VDR—multiple sclerosis	1.46e-05	0.00205	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—CD40—multiple sclerosis	1.43e-05	0.00201	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—PABPC1—multiple sclerosis	1.41e-05	0.00199	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	1.4e-05	0.00198	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—HNRNPA1—multiple sclerosis	1.4e-05	0.00198	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—U2AF2—multiple sclerosis	1.4e-05	0.00198	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—POMC—multiple sclerosis	1.39e-05	0.00196	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—RRM1—multiple sclerosis	1.38e-05	0.00194	CbGpPWpGaD
Betamethasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	1.36e-05	0.00191	CbGpPWpGaD
Betamethasone—ABCB1—brain—multiple sclerosis	1.34e-05	0.00543	CbGeAlD
Betamethasone—NR3C1—AP-1 transcription factor network—IFNG—multiple sclerosis	1.32e-05	0.00185	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—TYK2—multiple sclerosis	1.31e-05	0.00184	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—multiple sclerosis	1.31e-05	0.00184	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CXCL10—multiple sclerosis	1.3e-05	0.00183	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	1.28e-05	0.00181	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—RPL5—multiple sclerosis	1.27e-05	0.00179	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	1.24e-05	0.00174	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	1.24e-05	0.00174	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—FAS—multiple sclerosis	1.22e-05	0.00172	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	1.18e-05	0.00166	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—BDNF—multiple sclerosis	1.17e-05	0.00165	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—IL2—multiple sclerosis	1.17e-05	0.00165	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—ZNF746—multiple sclerosis	1.17e-05	0.00165	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—multiple sclerosis	1.16e-05	0.00163	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—multiple sclerosis	1.16e-05	0.00163	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	1.16e-05	0.00163	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	1.13e-05	0.0016	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	1.13e-05	0.0016	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	1.12e-05	0.00158	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	1.12e-05	0.00158	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—CD86—multiple sclerosis	1.11e-05	0.00157	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—ZFP36L1—multiple sclerosis	1.11e-05	0.00156	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—MMP9—multiple sclerosis	1.11e-05	0.00156	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—ICAM1—multiple sclerosis	1.09e-05	0.00154	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	1.09e-05	0.00154	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL10—multiple sclerosis	1.09e-05	0.00154	CbGpPWpGaD
Betamethasone—Prednisone—ALB—multiple sclerosis	1.09e-05	0.11	CrCbGaD
Betamethasone—PTGS2—Spinal Cord Injury—IL4—multiple sclerosis	1.09e-05	0.00153	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.07e-05	0.00151	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PTBP1—multiple sclerosis	1.07e-05	0.00151	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL4—multiple sclerosis	1.06e-05	0.0015	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—LINGO1—multiple sclerosis	1.05e-05	0.00148	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	1.04e-05	0.00146	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—IL2—multiple sclerosis	1.03e-05	0.00145	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—PGR—multiple sclerosis	1e-05	0.00141	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.98e-06	0.0014	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.98e-06	0.0014	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	9.92e-06	0.0014	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—FAS—multiple sclerosis	9.79e-06	0.00138	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—CCL2—multiple sclerosis	9.77e-06	0.00138	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	9.74e-06	0.00137	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	9.7e-06	0.00137	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	9.63e-06	0.00136	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	9.49e-06	0.00134	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—SRM—multiple sclerosis	9.44e-06	0.00133	CbGpPWpGaD
Betamethasone—NR3C1—Endoderm Differentiation—TGFB1—multiple sclerosis	9.34e-06	0.00132	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.2e-06	0.00129	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—MYC—multiple sclerosis	9.15e-06	0.00129	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—TGFB1—multiple sclerosis	9.13e-06	0.00129	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TAGAP—multiple sclerosis	9.12e-06	0.00128	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—ALB—multiple sclerosis	9.11e-06	0.00128	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	9.04e-06	0.00127	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TLR4—multiple sclerosis	9.01e-06	0.00127	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—VDR—multiple sclerosis	8.86e-06	0.00125	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	8.79e-06	0.00124	CbGpPWpGaD
Betamethasone—CYP19A1—Biological oxidations—POMC—multiple sclerosis	8.75e-06	0.00123	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—ICAM1—multiple sclerosis	8.64e-06	0.00122	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—PABPC1—multiple sclerosis	8.6e-06	0.00121	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	8.46e-06	0.00119	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.39e-06	0.00118	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—CD4—multiple sclerosis	8.33e-06	0.00117	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—MAPK1—multiple sclerosis	8.33e-06	0.00117	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—IFNG—multiple sclerosis	8.31e-06	0.00117	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	8.14e-06	0.00115	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—CD80—multiple sclerosis	8.13e-06	0.00114	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—HNRNPA1—multiple sclerosis	8.11e-06	0.00114	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—U2AF2—multiple sclerosis	8.11e-06	0.00114	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—S1PR1—multiple sclerosis	7.97e-06	0.00112	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	7.96e-06	0.00112	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—BCHE—multiple sclerosis	7.93e-06	0.00112	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—multiple sclerosis	7.89e-06	0.00111	CbGpPWpGaD
Betamethasone—Paraesthesia—Mitoxantrone—multiple sclerosis	7.87e-06	0.000163	CcSEcCtD
Betamethasone—PGR—Gene Expression—RPL5—multiple sclerosis	7.76e-06	0.00109	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—GPC5—multiple sclerosis	7.76e-06	0.00109	CbGpPWpGaD
Betamethasone—Loss of consciousness—Prednisolone—multiple sclerosis	7.74e-06	0.00016	CcSEcCtD
Betamethasone—PTGS2—Spinal Cord Injury—CCL2—multiple sclerosis	7.73e-06	0.00109	CbGpPWpGaD
Betamethasone—Dyspepsia—Mitoxantrone—multiple sclerosis	7.71e-06	0.00016	CcSEcCtD
Betamethasone—Angiopathy—Dexamethasone—multiple sclerosis	7.66e-06	0.000159	CcSEcCtD
Betamethasone—Convulsion—Prednisolone—multiple sclerosis	7.63e-06	0.000158	CcSEcCtD
Betamethasone—Decreased appetite—Mitoxantrone—multiple sclerosis	7.62e-06	0.000158	CcSEcCtD
Betamethasone—Hypertension—Prednisolone—multiple sclerosis	7.61e-06	0.000158	CcSEcCtD
Betamethasone—Fatigue—Mitoxantrone—multiple sclerosis	7.56e-06	0.000157	CcSEcCtD
Betamethasone—Arrhythmia—Dexamethasone—multiple sclerosis	7.54e-06	0.000156	CcSEcCtD
Betamethasone—Ill-defined disorder—Triamcinolone—multiple sclerosis	7.52e-06	0.000156	CcSEcCtD
Betamethasone—Ill-defined disorder—Methylprednisolone—multiple sclerosis	7.5e-06	0.000155	CcSEcCtD
Betamethasone—Pain—Mitoxantrone—multiple sclerosis	7.49e-06	0.000155	CcSEcCtD
Betamethasone—Bradycardia—Prednisone—multiple sclerosis	7.49e-06	0.000155	CcSEcCtD
Betamethasone—Alopecia—Dexamethasone—multiple sclerosis	7.46e-06	0.000155	CcSEcCtD
Betamethasone—Diarrhoea—Azathioprine—multiple sclerosis	7.42e-06	0.000154	CcSEcCtD
Betamethasone—PTGS2—Selenium Micronutrient Network—IL1B—multiple sclerosis	7.41e-06	0.00104	CbGpPWpGaD
Betamethasone—Discomfort—Prednisolone—multiple sclerosis	7.41e-06	0.000154	CcSEcCtD
Betamethasone—Angioedema—Triamcinolone—multiple sclerosis	7.4e-06	0.000153	CcSEcCtD
Betamethasone—Haemoglobin—Prednisone—multiple sclerosis	7.39e-06	0.000153	CcSEcCtD
Betamethasone—Angioedema—Methylprednisolone—multiple sclerosis	7.39e-06	0.000153	CcSEcCtD
Betamethasone—Haemorrhage—Prednisone—multiple sclerosis	7.35e-06	0.000152	CcSEcCtD
Betamethasone—Erythema—Dexamethasone—multiple sclerosis	7.35e-06	0.000152	CcSEcCtD
Betamethasone—NR3C1—Generic Transcription Pathway—PGR—multiple sclerosis	7.33e-06	0.00103	CbGpPWpGaD
Betamethasone—Hallucination—Prednisone—multiple sclerosis	7.32e-06	0.000152	CcSEcCtD
Betamethasone—Malaise—Triamcinolone—multiple sclerosis	7.31e-06	0.000151	CcSEcCtD
Betamethasone—Malaise—Methylprednisolone—multiple sclerosis	7.29e-06	0.000151	CcSEcCtD
Betamethasone—Vertigo—Triamcinolone—multiple sclerosis	7.28e-06	0.000151	CcSEcCtD
Betamethasone—Syncope—Triamcinolone—multiple sclerosis	7.27e-06	0.000151	CcSEcCtD
Betamethasone—Vertigo—Methylprednisolone—multiple sclerosis	7.26e-06	0.000151	CcSEcCtD
Betamethasone—Syncope—Methylprednisolone—multiple sclerosis	7.25e-06	0.00015	CcSEcCtD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.23e-06	0.00102	CbGpPWpGaD
Betamethasone—Feeling abnormal—Mitoxantrone—multiple sclerosis	7.22e-06	0.00015	CcSEcCtD
Betamethasone—Oedema—Prednisolone—multiple sclerosis	7.19e-06	0.000149	CcSEcCtD
Betamethasone—Anaphylactic shock—Prednisolone—multiple sclerosis	7.19e-06	0.000149	CcSEcCtD
Betamethasone—Dizziness—Azathioprine—multiple sclerosis	7.17e-06	0.000149	CcSEcCtD
Betamethasone—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	7.17e-06	0.000149	CcSEcCtD
Betamethasone—Loss of consciousness—Triamcinolone—multiple sclerosis	7.12e-06	0.000148	CcSEcCtD
Betamethasone—Loss of consciousness—Methylprednisolone—multiple sclerosis	7.11e-06	0.000147	CcSEcCtD
Betamethasone—Shock—Prednisolone—multiple sclerosis	7.07e-06	0.000147	CcSEcCtD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	7.03e-06	0.00099	CbGpPWpGaD
Betamethasone—Convulsion—Triamcinolone—multiple sclerosis	7.02e-06	0.000145	CcSEcCtD
Betamethasone—Tachycardia—Prednisolone—multiple sclerosis	7.02e-06	0.000145	CcSEcCtD
Betamethasone—NR3C2—Gene Expression—VDR—multiple sclerosis	7.01e-06	0.000986	CbGpPWpGaD
Betamethasone—Convulsion—Methylprednisolone—multiple sclerosis	7e-06	0.000145	CcSEcCtD
Betamethasone—Hypertension—Triamcinolone—multiple sclerosis	7e-06	0.000145	CcSEcCtD
Betamethasone—Hypertension—Methylprednisolone—multiple sclerosis	6.98e-06	0.000145	CcSEcCtD
Betamethasone—Urticaria—Mitoxantrone—multiple sclerosis	6.96e-06	0.000144	CcSEcCtD
Betamethasone—Hyperhidrosis—Prednisolone—multiple sclerosis	6.95e-06	0.000144	CcSEcCtD
Betamethasone—Abdominal pain—Mitoxantrone—multiple sclerosis	6.93e-06	0.000144	CcSEcCtD
Betamethasone—Body temperature increased—Mitoxantrone—multiple sclerosis	6.93e-06	0.000144	CcSEcCtD
Betamethasone—Myalgia—Triamcinolone—multiple sclerosis	6.9e-06	0.000143	CcSEcCtD
Betamethasone—Vomiting—Azathioprine—multiple sclerosis	6.89e-06	0.000143	CcSEcCtD
Betamethasone—Myalgia—Methylprednisolone—multiple sclerosis	6.88e-06	0.000143	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—IL6—multiple sclerosis	6.88e-06	0.000968	CbGpPWpGaD
Betamethasone—Eye disorder—Prednisone—multiple sclerosis	6.87e-06	0.000142	CcSEcCtD
Betamethasone—Anxiety—Methylprednisolone—multiple sclerosis	6.86e-06	0.000142	CcSEcCtD
Betamethasone—Rash—Azathioprine—multiple sclerosis	6.84e-06	0.000142	CcSEcCtD
Betamethasone—Dermatitis—Azathioprine—multiple sclerosis	6.83e-06	0.000142	CcSEcCtD
Betamethasone—Ill-defined disorder—Dexamethasone—multiple sclerosis	6.82e-06	0.000141	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	6.82e-06	0.00096	CbGpPWpGaD
Betamethasone—Discomfort—Triamcinolone—multiple sclerosis	6.82e-06	0.000141	CcSEcCtD
Betamethasone—Discomfort—Methylprednisolone—multiple sclerosis	6.8e-06	0.000141	CcSEcCtD
Betamethasone—Headache—Azathioprine—multiple sclerosis	6.79e-06	0.000141	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—RGS1—multiple sclerosis	6.78e-06	0.000954	CbGpPWpGaD
Betamethasone—Angioedema—Dexamethasone—multiple sclerosis	6.72e-06	0.000139	CcSEcCtD
Betamethasone—Angiopathy—Prednisone—multiple sclerosis	6.67e-06	0.000138	CcSEcCtD
Betamethasone—Conjunctivitis—Methotrexate—multiple sclerosis	6.66e-06	0.000138	CcSEcCtD
Betamethasone—CYP19A1—Metabolism—CYP24A1—multiple sclerosis	6.65e-06	0.000936	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CYP27B1—multiple sclerosis	6.65e-06	0.000936	CbGpPWpGaD
Betamethasone—Malaise—Dexamethasone—multiple sclerosis	6.63e-06	0.000137	CcSEcCtD
Betamethasone—Anaphylactic shock—Triamcinolone—multiple sclerosis	6.61e-06	0.000137	CcSEcCtD
Betamethasone—Oedema—Triamcinolone—multiple sclerosis	6.61e-06	0.000137	CcSEcCtD
Betamethasone—Vertigo—Dexamethasone—multiple sclerosis	6.6e-06	0.000137	CcSEcCtD
Betamethasone—Anaphylactic shock—Methylprednisolone—multiple sclerosis	6.6e-06	0.000137	CcSEcCtD
Betamethasone—Syncope—Dexamethasone—multiple sclerosis	6.59e-06	0.000137	CcSEcCtD
Betamethasone—PTGS2—Spinal Cord Injury—IFNG—multiple sclerosis	6.57e-06	0.000925	CbGpPWpGaD
Betamethasone—Arrhythmia—Prednisone—multiple sclerosis	6.57e-06	0.000136	CcSEcCtD
Betamethasone—Infection—Triamcinolone—multiple sclerosis	6.57e-06	0.000136	CcSEcCtD
Betamethasone—Infection—Methylprednisolone—multiple sclerosis	6.55e-06	0.000136	CcSEcCtD
Betamethasone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	6.54e-06	0.000921	CbGpPWpGaD
Betamethasone—Shock—Triamcinolone—multiple sclerosis	6.51e-06	0.000135	CcSEcCtD
Betamethasone—Insomnia—Prednisolone—multiple sclerosis	6.5e-06	0.000135	CcSEcCtD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.5e-06	0.000915	CbGpPWpGaD
Betamethasone—Alopecia—Prednisone—multiple sclerosis	6.5e-06	0.000135	CcSEcCtD
Betamethasone—Shock—Methylprednisolone—multiple sclerosis	6.49e-06	0.000135	CcSEcCtD
Betamethasone—Nervous system disorder—Methylprednisolone—multiple sclerosis	6.47e-06	0.000134	CcSEcCtD
Betamethasone—Loss of consciousness—Dexamethasone—multiple sclerosis	6.46e-06	0.000134	CcSEcCtD
Betamethasone—Paraesthesia—Prednisolone—multiple sclerosis	6.46e-06	0.000134	CcSEcCtD
Betamethasone—Tachycardia—Triamcinolone—multiple sclerosis	6.45e-06	0.000134	CcSEcCtD
Betamethasone—Nausea—Azathioprine—multiple sclerosis	6.44e-06	0.000133	CcSEcCtD
Betamethasone—Tachycardia—Methylprednisolone—multiple sclerosis	6.44e-06	0.000133	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—GPR65—multiple sclerosis	6.43e-06	0.000905	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	6.42e-06	0.000904	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—ZFP36L1—multiple sclerosis	6.41e-06	0.000902	CbGpPWpGaD
Betamethasone—Erythema—Prednisone—multiple sclerosis	6.4e-06	0.000133	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—IL6—multiple sclerosis	6.4e-06	0.000901	CbGpPWpGaD
Betamethasone—Hyperhidrosis—Triamcinolone—multiple sclerosis	6.39e-06	0.000132	CcSEcCtD
Betamethasone—Hyperhidrosis—Methylprednisolone—multiple sclerosis	6.38e-06	0.000132	CcSEcCtD
Betamethasone—Convulsion—Dexamethasone—multiple sclerosis	6.37e-06	0.000132	CcSEcCtD
Betamethasone—Hypertension—Dexamethasone—multiple sclerosis	6.35e-06	0.000132	CcSEcCtD
Betamethasone—PTGS2—Metabolism—SRM—multiple sclerosis	6.31e-06	0.000888	CbGpPWpGaD
Betamethasone—Asthenia—Mitoxantrone—multiple sclerosis	6.29e-06	0.00013	CcSEcCtD
Betamethasone—Myalgia—Dexamethasone—multiple sclerosis	6.26e-06	0.00013	CcSEcCtD
Betamethasone—Anxiety—Dexamethasone—multiple sclerosis	6.24e-06	0.000129	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	6.19e-06	0.000871	CbGpPWpGaD
Betamethasone—Discomfort—Dexamethasone—multiple sclerosis	6.18e-06	0.000128	CcSEcCtD
Betamethasone—Haemoglobin—Methotrexate—multiple sclerosis	6.18e-06	0.000128	CcSEcCtD
Betamethasone—Hypotension—Methylprednisolone—multiple sclerosis	6.17e-06	0.000128	CcSEcCtD
Betamethasone—Pain—Prednisolone—multiple sclerosis	6.15e-06	0.000127	CcSEcCtD
Betamethasone—Haemorrhage—Methotrexate—multiple sclerosis	6.15e-06	0.000127	CcSEcCtD
Betamethasone—CYP19A1—Metabolism—GPC5—multiple sclerosis	6.08e-06	0.000856	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—multiple sclerosis	6.06e-06	0.000853	CbGpPWpGaD
Betamethasone—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	6.02e-06	0.000125	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	6.01e-06	0.000125	CcSEcCtD
Betamethasone—NR3C1—Adipogenesis—STAT3—multiple sclerosis	6e-06	0.000845	CbGpPWpGaD
Betamethasone—Oedema—Dexamethasone—multiple sclerosis	6e-06	0.000124	CcSEcCtD
Betamethasone—Anaphylactic shock—Dexamethasone—multiple sclerosis	6e-06	0.000124	CcSEcCtD
Betamethasone—Diarrhoea—Mitoxantrone—multiple sclerosis	6e-06	0.000124	CcSEcCtD
Betamethasone—PTGS2—C-MYB transcription factor network—MYC—multiple sclerosis	5.99e-06	0.000844	CbGpPWpGaD
Betamethasone—Insomnia—Triamcinolone—multiple sclerosis	5.98e-06	0.000124	CcSEcCtD
Betamethasone—Insomnia—Methylprednisolone—multiple sclerosis	5.97e-06	0.000124	CcSEcCtD
Betamethasone—Infection—Dexamethasone—multiple sclerosis	5.96e-06	0.000124	CcSEcCtD
Betamethasone—Ill-defined disorder—Prednisone—multiple sclerosis	5.94e-06	0.000123	CcSEcCtD
Betamethasone—Paraesthesia—Triamcinolone—multiple sclerosis	5.94e-06	0.000123	CcSEcCtD
Betamethasone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.93e-06	0.000834	CbGpPWpGaD
Betamethasone—Feeling abnormal—Prednisolone—multiple sclerosis	5.93e-06	0.000123	CcSEcCtD
Betamethasone—Paraesthesia—Methylprednisolone—multiple sclerosis	5.92e-06	0.000123	CcSEcCtD
Betamethasone—Visual impairment—Methotrexate—multiple sclerosis	5.92e-06	0.000123	CcSEcCtD
Betamethasone—Shock—Dexamethasone—multiple sclerosis	5.9e-06	0.000122	CcSEcCtD
Betamethasone—Nervous system disorder—Dexamethasone—multiple sclerosis	5.88e-06	0.000122	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—CCR1—multiple sclerosis	5.88e-06	0.000828	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CXCL13—multiple sclerosis	5.88e-06	0.000828	CbGpPWpGaD
Betamethasone—Thrombocytopenia—Dexamethasone—multiple sclerosis	5.87e-06	0.000122	CcSEcCtD
Betamethasone—PTGS2—Spinal Cord Injury—IL1B—multiple sclerosis	5.86e-06	0.000825	CbGpPWpGaD
Betamethasone—Tachycardia—Dexamethasone—multiple sclerosis	5.86e-06	0.000121	CcSEcCtD
Betamethasone—Angioedema—Prednisone—multiple sclerosis	5.85e-06	0.000121	CcSEcCtD
Betamethasone—PTGS2—Spinal Cord Injury—IL2—multiple sclerosis	5.84e-06	0.000822	CbGpPWpGaD
Betamethasone—Dyspepsia—Triamcinolone—multiple sclerosis	5.82e-06	0.000121	CcSEcCtD
Betamethasone—Dyspepsia—Methylprednisolone—multiple sclerosis	5.81e-06	0.00012	CcSEcCtD
Betamethasone—Hyperhidrosis—Dexamethasone—multiple sclerosis	5.8e-06	0.00012	CcSEcCtD
Betamethasone—NR3C2—Generic Transcription Pathway—MYC—multiple sclerosis	5.78e-06	0.000814	CbGpPWpGaD
Betamethasone—Malaise—Prednisone—multiple sclerosis	5.77e-06	0.00012	CcSEcCtD
Betamethasone—Vertigo—Prednisone—multiple sclerosis	5.75e-06	0.000119	CcSEcCtD
Betamethasone—Eye disorder—Methotrexate—multiple sclerosis	5.74e-06	0.000119	CcSEcCtD
Betamethasone—Syncope—Prednisone—multiple sclerosis	5.74e-06	0.000119	CcSEcCtD
Betamethasone—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	5.73e-06	0.000806	CbGpPWpGaD
Betamethasone—Anorexia—Dexamethasone—multiple sclerosis	5.72e-06	0.000119	CcSEcCtD
Betamethasone—Urticaria—Prednisolone—multiple sclerosis	5.71e-06	0.000118	CcSEcCtD
Betamethasone—ABCB1—Allograft Rejection—IL2—multiple sclerosis	5.71e-06	0.000803	CbGpPWpGaD
Betamethasone—Fatigue—Triamcinolone—multiple sclerosis	5.7e-06	0.000118	CcSEcCtD
Betamethasone—Fatigue—Methylprednisolone—multiple sclerosis	5.69e-06	0.000118	CcSEcCtD
Betamethasone—Pain—Triamcinolone—multiple sclerosis	5.65e-06	0.000117	CcSEcCtD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	5.65e-06	0.000795	CbGpPWpGaD
Betamethasone—Loss of consciousness—Prednisone—multiple sclerosis	5.63e-06	0.000117	CcSEcCtD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	5.61e-06	0.00079	CbGpPWpGaD
Betamethasone—Hypotension—Dexamethasone—multiple sclerosis	5.61e-06	0.000116	CcSEcCtD
Betamethasone—Angiopathy—Methotrexate—multiple sclerosis	5.58e-06	0.000116	CcSEcCtD
Betamethasone—Vomiting—Mitoxantrone—multiple sclerosis	5.57e-06	0.000115	CcSEcCtD
Betamethasone—NR3C1—Adipogenesis—TGFB1—multiple sclerosis	5.56e-06	0.000783	CbGpPWpGaD
Betamethasone—Convulsion—Prednisone—multiple sclerosis	5.55e-06	0.000115	CcSEcCtD
Betamethasone—PTGS2—Spinal Cord Injury—MMP9—multiple sclerosis	5.53e-06	0.000778	CbGpPWpGaD
Betamethasone—Hypertension—Prednisone—multiple sclerosis	5.53e-06	0.000115	CcSEcCtD
Betamethasone—Rash—Mitoxantrone—multiple sclerosis	5.53e-06	0.000115	CcSEcCtD
Betamethasone—Dermatitis—Mitoxantrone—multiple sclerosis	5.52e-06	0.000114	CcSEcCtD
Betamethasone—Headache—Mitoxantrone—multiple sclerosis	5.49e-06	0.000114	CcSEcCtD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	5.49e-06	0.000773	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.48e-06	0.000772	CbGpPWpGaD
Betamethasone—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	5.47e-06	0.000113	CcSEcCtD
Betamethasone—Myalgia—Prednisone—multiple sclerosis	5.45e-06	0.000113	CcSEcCtD
Betamethasone—Feeling abnormal—Triamcinolone—multiple sclerosis	5.45e-06	0.000113	CcSEcCtD
Betamethasone—Feeling abnormal—Methylprednisolone—multiple sclerosis	5.44e-06	0.000113	CcSEcCtD
Betamethasone—Anxiety—Prednisone—multiple sclerosis	5.43e-06	0.000113	CcSEcCtD
Betamethasone—Alopecia—Methotrexate—multiple sclerosis	5.43e-06	0.000113	CcSEcCtD
Betamethasone—Insomnia—Dexamethasone—multiple sclerosis	5.43e-06	0.000112	CcSEcCtD
Betamethasone—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	5.4e-06	0.000112	CcSEcCtD
Betamethasone—Paraesthesia—Dexamethasone—multiple sclerosis	5.39e-06	0.000112	CcSEcCtD
Betamethasone—Discomfort—Prednisone—multiple sclerosis	5.39e-06	0.000112	CcSEcCtD
Betamethasone—PTGS2—Selenium Micronutrient Network—TNF—multiple sclerosis	5.38e-06	0.000757	CbGpPWpGaD
Betamethasone—Erythema—Methotrexate—multiple sclerosis	5.35e-06	0.000111	CcSEcCtD
Betamethasone—Dyspepsia—Dexamethasone—multiple sclerosis	5.28e-06	0.000109	CcSEcCtD
Betamethasone—Urticaria—Triamcinolone—multiple sclerosis	5.25e-06	0.000109	CcSEcCtD
Betamethasone—Urticaria—Methylprednisolone—multiple sclerosis	5.24e-06	0.000109	CcSEcCtD
Betamethasone—Body temperature increased—Triamcinolone—multiple sclerosis	5.23e-06	0.000108	CcSEcCtD
Betamethasone—Anaphylactic shock—Prednisone—multiple sclerosis	5.23e-06	0.000108	CcSEcCtD
Betamethasone—Oedema—Prednisone—multiple sclerosis	5.23e-06	0.000108	CcSEcCtD
Betamethasone—Abdominal pain—Methylprednisolone—multiple sclerosis	5.22e-06	0.000108	CcSEcCtD
Betamethasone—Decreased appetite—Dexamethasone—multiple sclerosis	5.22e-06	0.000108	CcSEcCtD
Betamethasone—Nausea—Mitoxantrone—multiple sclerosis	5.21e-06	0.000108	CcSEcCtD
Betamethasone—NR3C1—Adipogenesis—TNF—multiple sclerosis	5.19e-06	0.000731	CbGpPWpGaD
Betamethasone—Infection—Prednisone—multiple sclerosis	5.19e-06	0.000108	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	5.18e-06	0.000107	CcSEcCtD
Betamethasone—Fatigue—Dexamethasone—multiple sclerosis	5.17e-06	0.000107	CcSEcCtD
Betamethasone—Shock—Prednisone—multiple sclerosis	5.14e-06	0.000107	CcSEcCtD
Betamethasone—Pain—Dexamethasone—multiple sclerosis	5.13e-06	0.000106	CcSEcCtD
Betamethasone—Nervous system disorder—Prednisone—multiple sclerosis	5.12e-06	0.000106	CcSEcCtD
Betamethasone—NR3C1—Generic Transcription Pathway—VDR—multiple sclerosis	5.12e-06	0.000721	CbGpPWpGaD
Betamethasone—Tachycardia—Prednisone—multiple sclerosis	5.1e-06	0.000106	CcSEcCtD
Betamethasone—Hyperhidrosis—Prednisone—multiple sclerosis	5.05e-06	0.000105	CcSEcCtD
Betamethasone—CYP19A1—Metabolism—RRM1—multiple sclerosis	5.04e-06	0.000709	CbGpPWpGaD
Betamethasone—Anorexia—Prednisone—multiple sclerosis	4.98e-06	0.000103	CcSEcCtD
Betamethasone—NR3C1—Gene Expression—PABPC1—multiple sclerosis	4.97e-06	0.0007	CbGpPWpGaD
Betamethasone—Ill-defined disorder—Methotrexate—multiple sclerosis	4.96e-06	0.000103	CcSEcCtD
Betamethasone—Feeling abnormal—Dexamethasone—multiple sclerosis	4.94e-06	0.000102	CcSEcCtD
Betamethasone—Gastrointestinal pain—Dexamethasone—multiple sclerosis	4.91e-06	0.000102	CcSEcCtD
Betamethasone—PTGS2—Disease—GPC5—multiple sclerosis	4.85e-06	0.000683	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	4.83e-06	0.00068	CbGpPWpGaD
Betamethasone—Malaise—Methotrexate—multiple sclerosis	4.83e-06	0.0001	CcSEcCtD
Betamethasone—Vertigo—Methotrexate—multiple sclerosis	4.81e-06	9.96e-05	CcSEcCtD
Betamethasone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.81e-06	0.000676	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—APOE—multiple sclerosis	4.77e-06	0.000671	CbGpPWpGaD
Betamethasone—Urticaria—Dexamethasone—multiple sclerosis	4.77e-06	9.88e-05	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Prednisone—multiple sclerosis	4.76e-06	9.86e-05	CcSEcCtD
Betamethasone—Dizziness—Prednisolone—multiple sclerosis	4.75e-06	9.85e-05	CcSEcCtD
Betamethasone—Asthenia—Triamcinolone—multiple sclerosis	4.74e-06	9.83e-05	CcSEcCtD
Betamethasone—Body temperature increased—Dexamethasone—multiple sclerosis	4.74e-06	9.83e-05	CcSEcCtD
Betamethasone—Abdominal pain—Dexamethasone—multiple sclerosis	4.74e-06	9.83e-05	CcSEcCtD
Betamethasone—Asthenia—Methylprednisolone—multiple sclerosis	4.73e-06	9.81e-05	CcSEcCtD
Betamethasone—Insomnia—Prednisone—multiple sclerosis	4.73e-06	9.79e-05	CcSEcCtD
Betamethasone—Paraesthesia—Prednisone—multiple sclerosis	4.69e-06	9.72e-05	CcSEcCtD
Betamethasone—Pruritus—Triamcinolone—multiple sclerosis	4.68e-06	9.69e-05	CcSEcCtD
Betamethasone—Pruritus—Methylprednisolone—multiple sclerosis	4.67e-06	9.67e-05	CcSEcCtD
Betamethasone—Convulsion—Methotrexate—multiple sclerosis	4.64e-06	9.61e-05	CcSEcCtD
Betamethasone—Dyspepsia—Prednisone—multiple sclerosis	4.6e-06	9.53e-05	CcSEcCtD
Betamethasone—PTGS2—Spinal Cord Injury—MYC—multiple sclerosis	4.57e-06	0.000643	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TGFB1—multiple sclerosis	4.56e-06	0.000641	CbGpPWpGaD
Betamethasone—Myalgia—Methotrexate—multiple sclerosis	4.56e-06	9.44e-05	CcSEcCtD
Betamethasone—Decreased appetite—Prednisone—multiple sclerosis	4.54e-06	9.41e-05	CcSEcCtD
Betamethasone—Rash—Prednisolone—multiple sclerosis	4.53e-06	9.39e-05	CcSEcCtD
Betamethasone—Dermatitis—Prednisolone—multiple sclerosis	4.53e-06	9.39e-05	CcSEcCtD
Betamethasone—Diarrhoea—Methylprednisolone—multiple sclerosis	4.51e-06	9.35e-05	CcSEcCtD
Betamethasone—Fatigue—Prednisone—multiple sclerosis	4.5e-06	9.34e-05	CcSEcCtD
Betamethasone—Headache—Prednisolone—multiple sclerosis	4.5e-06	9.33e-05	CcSEcCtD
Betamethasone—Discomfort—Methotrexate—multiple sclerosis	4.5e-06	9.33e-05	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	4.49e-06	0.000632	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—RPL5—multiple sclerosis	4.48e-06	0.000631	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SRM—multiple sclerosis	4.47e-06	0.000629	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—MAPK1—multiple sclerosis	4.47e-06	0.000629	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	4.45e-06	0.000627	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP27B1—multiple sclerosis	4.44e-06	0.000625	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP24A1—multiple sclerosis	4.44e-06	0.000625	CbGpPWpGaD
Betamethasone—Dizziness—Triamcinolone—multiple sclerosis	4.37e-06	9.06e-05	CcSEcCtD
Betamethasone—Anaphylactic shock—Methotrexate—multiple sclerosis	4.37e-06	9.05e-05	CcSEcCtD
Betamethasone—Dizziness—Methylprednisolone—multiple sclerosis	4.36e-06	9.04e-05	CcSEcCtD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.34e-06	0.000611	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—IL6—multiple sclerosis	4.34e-06	0.000611	CbGpPWpGaD
Betamethasone—Infection—Methotrexate—multiple sclerosis	4.34e-06	8.99e-05	CcSEcCtD
Betamethasone—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.33e-06	0.00061	CbGpPWpGaD
Betamethasone—Feeling abnormal—Prednisone—multiple sclerosis	4.31e-06	8.92e-05	CcSEcCtD
Betamethasone—Asthenia—Dexamethasone—multiple sclerosis	4.3e-06	8.92e-05	CcSEcCtD
Betamethasone—Nervous system disorder—Methotrexate—multiple sclerosis	4.28e-06	8.87e-05	CcSEcCtD
Betamethasone—Thrombocytopenia—Methotrexate—multiple sclerosis	4.28e-06	8.86e-05	CcSEcCtD
Betamethasone—Gastrointestinal pain—Prednisone—multiple sclerosis	4.27e-06	8.85e-05	CcSEcCtD
Betamethasone—Nausea—Prednisolone—multiple sclerosis	4.27e-06	8.85e-05	CcSEcCtD
Betamethasone—PGR—Gene Expression—VDR—multiple sclerosis	4.27e-06	0.000601	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	4.25e-06	0.000599	CbGpPWpGaD
Betamethasone—Pruritus—Dexamethasone—multiple sclerosis	4.24e-06	8.8e-05	CcSEcCtD
Betamethasone—Hyperhidrosis—Methotrexate—multiple sclerosis	4.22e-06	8.75e-05	CcSEcCtD
Betamethasone—Vomiting—Triamcinolone—multiple sclerosis	4.2e-06	8.71e-05	CcSEcCtD
Betamethasone—Vomiting—Methylprednisolone—multiple sclerosis	4.19e-06	8.69e-05	CcSEcCtD
Betamethasone—NR3C1—Adipogenesis—IL6—multiple sclerosis	4.19e-06	0.00059	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCL3—multiple sclerosis	4.19e-06	0.00059	CbGpPWpGaD
Betamethasone—Rash—Triamcinolone—multiple sclerosis	4.17e-06	8.64e-05	CcSEcCtD
Betamethasone—Dermatitis—Triamcinolone—multiple sclerosis	4.17e-06	8.63e-05	CcSEcCtD
Betamethasone—Anorexia—Methotrexate—multiple sclerosis	4.16e-06	8.63e-05	CcSEcCtD
Betamethasone—Rash—Methylprednisolone—multiple sclerosis	4.16e-06	8.62e-05	CcSEcCtD
Betamethasone—ABCB1—Allograft Rejection—TNF—multiple sclerosis	4.16e-06	0.000585	CbGpPWpGaD
Betamethasone—Dermatitis—Methylprednisolone—multiple sclerosis	4.16e-06	8.61e-05	CcSEcCtD
Betamethasone—Urticaria—Prednisone—multiple sclerosis	4.15e-06	8.6e-05	CcSEcCtD
Betamethasone—Headache—Triamcinolone—multiple sclerosis	4.14e-06	8.58e-05	CcSEcCtD
Betamethasone—Headache—Methylprednisolone—multiple sclerosis	4.13e-06	8.57e-05	CcSEcCtD
Betamethasone—Abdominal pain—Prednisone—multiple sclerosis	4.13e-06	8.56e-05	CcSEcCtD
Betamethasone—Body temperature increased—Prednisone—multiple sclerosis	4.13e-06	8.56e-05	CcSEcCtD
Betamethasone—Diarrhoea—Dexamethasone—multiple sclerosis	4.11e-06	8.51e-05	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—POMC—multiple sclerosis	4.1e-06	0.000577	CbGpPWpGaD
Betamethasone—Hypotension—Methotrexate—multiple sclerosis	4.08e-06	8.46e-05	CcSEcCtD
Betamethasone—PTGS2—Metabolism—GPC5—multiple sclerosis	4.06e-06	0.000572	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTGER4—multiple sclerosis	4.03e-06	0.000568	CbGpPWpGaD
Betamethasone—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	3.98e-06	8.24e-05	CcSEcCtD
Betamethasone—Dizziness—Dexamethasone—multiple sclerosis	3.97e-06	8.22e-05	CcSEcCtD
Betamethasone—Insomnia—Methotrexate—multiple sclerosis	3.95e-06	8.18e-05	CcSEcCtD
Betamethasone—Nausea—Triamcinolone—multiple sclerosis	3.93e-06	8.14e-05	CcSEcCtD
Betamethasone—Paraesthesia—Methotrexate—multiple sclerosis	3.92e-06	8.13e-05	CcSEcCtD
Betamethasone—Nausea—Methylprednisolone—multiple sclerosis	3.92e-06	8.12e-05	CcSEcCtD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.91e-06	0.00055	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CXCR3—multiple sclerosis	3.89e-06	0.000548	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CD28—multiple sclerosis	3.86e-06	0.000543	CbGpPWpGaD
Betamethasone—Dyspepsia—Methotrexate—multiple sclerosis	3.84e-06	7.97e-05	CcSEcCtD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.83e-06	0.000539	CbGpPWpGaD
Betamethasone—Vomiting—Dexamethasone—multiple sclerosis	3.81e-06	7.91e-05	CcSEcCtD
Betamethasone—Decreased appetite—Methotrexate—multiple sclerosis	3.8e-06	7.87e-05	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—CCR2—multiple sclerosis	3.79e-06	0.000533	CbGpPWpGaD
Betamethasone—Rash—Dexamethasone—multiple sclerosis	3.78e-06	7.84e-05	CcSEcCtD
Betamethasone—Dermatitis—Dexamethasone—multiple sclerosis	3.78e-06	7.83e-05	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Methotrexate—multiple sclerosis	3.77e-06	7.81e-05	CcSEcCtD
Betamethasone—Fatigue—Methotrexate—multiple sclerosis	3.76e-06	7.8e-05	CcSEcCtD
Betamethasone—Headache—Dexamethasone—multiple sclerosis	3.76e-06	7.79e-05	CcSEcCtD
Betamethasone—Asthenia—Prednisone—multiple sclerosis	3.75e-06	7.77e-05	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—ALB—multiple sclerosis	3.73e-06	0.000526	CbGpPWpGaD
Betamethasone—Pain—Methotrexate—multiple sclerosis	3.73e-06	7.74e-05	CcSEcCtD
Betamethasone—Pruritus—Prednisone—multiple sclerosis	3.7e-06	7.66e-05	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	3.62e-06	0.00051	CbGpPWpGaD
Betamethasone—Feeling abnormal—Methotrexate—multiple sclerosis	3.6e-06	7.46e-05	CcSEcCtD
Betamethasone—Diarrhoea—Prednisone—multiple sclerosis	3.58e-06	7.41e-05	CcSEcCtD
Betamethasone—Gastrointestinal pain—Methotrexate—multiple sclerosis	3.57e-06	7.4e-05	CcSEcCtD
Betamethasone—Nausea—Dexamethasone—multiple sclerosis	3.56e-06	7.39e-05	CcSEcCtD
Betamethasone—NR3C1—Gene Expression—PGR—multiple sclerosis	3.53e-06	0.000497	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—MYC—multiple sclerosis	3.52e-06	0.000496	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CNR1—multiple sclerosis	3.5e-06	0.000492	CbGpPWpGaD
Betamethasone—Urticaria—Methotrexate—multiple sclerosis	3.47e-06	7.19e-05	CcSEcCtD
Betamethasone—Dizziness—Prednisone—multiple sclerosis	3.46e-06	7.16e-05	CcSEcCtD
Betamethasone—Body temperature increased—Methotrexate—multiple sclerosis	3.45e-06	7.15e-05	CcSEcCtD
Betamethasone—Abdominal pain—Methotrexate—multiple sclerosis	3.45e-06	7.15e-05	CcSEcCtD
Betamethasone—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	3.43e-06	0.000483	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—RRM1—multiple sclerosis	3.37e-06	0.000474	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.36e-06	0.000473	CbGpPWpGaD
Betamethasone—Vomiting—Prednisone—multiple sclerosis	3.32e-06	6.88e-05	CcSEcCtD
Betamethasone—Rash—Prednisone—multiple sclerosis	3.29e-06	6.83e-05	CcSEcCtD
Betamethasone—Dermatitis—Prednisone—multiple sclerosis	3.29e-06	6.82e-05	CcSEcCtD
Betamethasone—Headache—Prednisone—multiple sclerosis	3.27e-06	6.78e-05	CcSEcCtD
Betamethasone—PTGS2—Disease—RPL5—multiple sclerosis	3.16e-06	0.000444	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP27B1—multiple sclerosis	3.15e-06	0.000443	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP24A1—multiple sclerosis	3.15e-06	0.000443	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CXCL10—multiple sclerosis	3.15e-06	0.000443	CbGpPWpGaD
Betamethasone—Asthenia—Methotrexate—multiple sclerosis	3.13e-06	6.49e-05	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	3.11e-06	0.000437	CbGpPWpGaD
Betamethasone—Nausea—Prednisone—multiple sclerosis	3.1e-06	6.43e-05	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	3.1e-06	0.000436	CbGpPWpGaD
Betamethasone—Pruritus—Methotrexate—multiple sclerosis	3.09e-06	6.4e-05	CcSEcCtD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.06e-06	0.000431	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	3.04e-06	0.000428	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SLC11A1—multiple sclerosis	3.02e-06	0.000425	CbGpPWpGaD
Betamethasone—Diarrhoea—Methotrexate—multiple sclerosis	2.99e-06	6.19e-05	CcSEcCtD
Betamethasone—CYP19A1—Metabolism—BCHE—multiple sclerosis	2.89e-06	0.000407	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.89e-06	0.000407	CbGpPWpGaD
Betamethasone—Dizziness—Methotrexate—multiple sclerosis	2.89e-06	5.98e-05	CcSEcCtD
Betamethasone—ABCB1—Metabolism—GPC5—multiple sclerosis	2.88e-06	0.000406	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—MYC—multiple sclerosis	2.79e-06	0.000392	CbGpPWpGaD
Betamethasone—Vomiting—Methotrexate—multiple sclerosis	2.78e-06	5.75e-05	CcSEcCtD
Betamethasone—CYP3A4—Metabolism—SRM—multiple sclerosis	2.75e-06	0.000388	CbGpPWpGaD
Betamethasone—Rash—Methotrexate—multiple sclerosis	2.75e-06	5.71e-05	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—CD86—multiple sclerosis	2.75e-06	0.000387	CbGpPWpGaD
Betamethasone—Dermatitis—Methotrexate—multiple sclerosis	2.75e-06	5.7e-05	CcSEcCtD
Betamethasone—Headache—Methotrexate—multiple sclerosis	2.74e-06	5.67e-05	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—CCL5—multiple sclerosis	2.71e-06	0.000381	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.61e-06	0.000368	CbGpPWpGaD
Betamethasone—Nausea—Methotrexate—multiple sclerosis	2.59e-06	5.37e-05	CcSEcCtD
Betamethasone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.55e-06	0.000359	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SPP1—multiple sclerosis	2.51e-06	0.000353	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—VDR—multiple sclerosis	2.47e-06	0.000347	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCR5—multiple sclerosis	2.44e-06	0.000344	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CD28—multiple sclerosis	2.41e-06	0.00034	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL2RA—multiple sclerosis	2.41e-06	0.000339	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—RRM1—multiple sclerosis	2.39e-06	0.000336	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.24e-06	0.000316	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—APOE—multiple sclerosis	2.22e-06	0.000313	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.2e-06	0.00031	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.2e-06	0.000309	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.15e-06	0.000303	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.05e-06	0.000289	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.05e-06	0.000288	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—MYC—multiple sclerosis	2.04e-06	0.000287	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CD80—multiple sclerosis	2.01e-06	0.000283	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.94e-06	0.000273	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.94e-06	0.000273	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—BCHE—multiple sclerosis	1.93e-06	0.000272	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—POMC—multiple sclerosis	1.91e-06	0.000269	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCL2—multiple sclerosis	1.87e-06	0.000263	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.77e-06	0.00025	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—APOE—multiple sclerosis	1.74e-06	0.000245	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CD86—multiple sclerosis	1.72e-06	0.000242	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MYC—multiple sclerosis	1.7e-06	0.000239	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TYK2—multiple sclerosis	1.7e-06	0.000239	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CCR5—multiple sclerosis	1.53e-06	0.000215	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—POMC—multiple sclerosis	1.5e-06	0.000211	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HLA-A—multiple sclerosis	1.49e-06	0.000209	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.47e-06	0.000207	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL2—multiple sclerosis	1.41e-06	0.000199	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APOE—multiple sclerosis	1.39e-06	0.000196	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.38e-06	0.000194	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—BCHE—multiple sclerosis	1.37e-06	0.000193	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ALB—multiple sclerosis	1.36e-06	0.000192	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MMP9—multiple sclerosis	1.33e-06	0.000188	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CD80—multiple sclerosis	1.26e-06	0.000177	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—STAT3—multiple sclerosis	1.19e-06	0.000167	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—APOE—multiple sclerosis	1.16e-06	0.000164	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MYC—multiple sclerosis	1.1e-06	0.000155	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TGFB1—multiple sclerosis	1.1e-06	0.000155	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAPK1—multiple sclerosis	1.08e-06	0.000152	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TYK2—multiple sclerosis	1.06e-06	0.000149	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—POMC—multiple sclerosis	9.99e-07	0.000141	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MYC—multiple sclerosis	9.8e-07	0.000138	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CD4—multiple sclerosis	9.59e-07	0.000135	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ALB—multiple sclerosis	9.11e-07	0.000128	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—BCHE—multiple sclerosis	8.45e-07	0.000119	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL6—multiple sclerosis	8.29e-07	0.000117	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—APOE—multiple sclerosis	8.25e-07	0.000116	CbGpPWpGaD
Betamethasone—PTGS2—Disease—STAT3—multiple sclerosis	7.42e-07	0.000105	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—POMC—multiple sclerosis	7.08e-07	9.97e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MYC—multiple sclerosis	6.9e-07	9.71e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TGFB1—multiple sclerosis	6.88e-07	9.69e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MAPK1—multiple sclerosis	6.75e-07	9.5e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ALB—multiple sclerosis	6.46e-07	9.09e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IL6—multiple sclerosis	5.19e-07	7.3e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—APOE—multiple sclerosis	5.08e-07	7.15e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—POMC—multiple sclerosis	4.37e-07	6.14e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ALB—multiple sclerosis	3.98e-07	5.6e-05	CbGpPWpGaD
